Duramycin is a small post-translationally modified peptide with antibody-like affinity for phosphatidylethanolamine. As it turns out, the same functionality that is essential for duramycin activity helps to catalyze the formation of its conformationally constrained and compact polycyclic architecture.
References
Arnison, P. G. et al. Nat. Prod. Rep. 30, 108–160 (2013).
An, L. et al. Nat. Chem. Biol. https://doi.org/10.1038/s41589-018-0122-4 (2018).
Makino, A. et al. J. Biol. Chem. 278, 3204–3209 (2003).
Hosoda, K. et al. J. Biochem. 119, 226–230 (1996).
Ökesli, A., Cooper, L. E., Fogle, E. J. & van der Donk, W. A. J. Am. Chem. Soc. 133, 13753–13760 (2011).
Dall’Acqua, W. & Carter, P. Protein Sci. 9, 1–9 (2000).
Carter, P. & Wells, J. A. Science 237, 394–399 (1987).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
About this article
Cite this article
Bowers, A.A. The substrate lends a hand. Nat Chem Biol 14, 907–908 (2018). https://doi.org/10.1038/s41589-018-0135-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41589-018-0135-z
- Springer Nature America, Inc.